Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Environmental Science and Pollution Research International|March 28, 2020
Assessment and source quantification of heavy metal(loid)s in surface water using multivariate analyses from the Saigon River, VietnamBinh Thanh Nguyen, Vinh Ngoc Nguyen, Huong Thu Thi Truong, et al.
Cell Death and Differentiation|August 5, 2026
MDM2 binds and suppresses RNA polymerase III to restrain the innate immune response to cytosolic DNASabrina Weber, Valentina Manzini, Helene Dietrich, et al.
Cell Death Discovery|July 21, 2023
CAMK2D: a novel molecular target for BAP1-deficient malignant mesotheliomaSivasundaram Karnan, Akinobu Ota, Hideki Murakami, et al.
Marine Drugs|June 25, 2026
Ascophyllan Supplementation Is Safe and Associated with Exploratory Modulation of Innate Immune Phenotypes, Biochemical Parameters, and the Gut Microbiome in a Randomized Pilot TrialShohei Mizuno, Jorge Luis Espinoza, Lam Quang Vu, et al.
Methods (San Diego, Calif.)|June 12, 2025
Characterization of targeted knock-in achieved via tandem paired nicking mediated by CRISPR/Cas9 nickasesMd Towhid Ahmed Shihan, Toshinori Hyodo, Takeshi Fujino, et al.
Frontiers in Surgery|October 27, 2023
Clinical presentation, management and outcomes of bile duct injuries after laparoscopic cholecystectomy: a 15-year single-center experience in VietnamHung Quang Vu, Duc Trong Quach, Bac Hoang Nguyen, et al.
Cell Death Discovery|January 28, 2024
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cellsSivasundaram Karnan, Ichiro Hanamura, Akinobu Ota, et al.
Cell Death & Disease|March 1, 2026
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesotheliomaSivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, et al.
Cell Death & Disease|June 23, 2026
Nintedanib inhibits the VEGFR-ERK signaling pathway in human KRAS-mutated cancer cellsSivasundaram Karnan, Akinobu Ota, Muhammad Nazmul Hasan, et al.
Nature Communications|April 1, 2025
Lysine-arginine imbalance overcomes therapeutic tolerance governed by the transcription factor E3-lysosome axis in glioblastomaYongwei Jing, Masahiko Kobayashi, Mahmoud I Shoulkamy, et al.
Pageof 9